Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Valldeoriola

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Journal of Neurology|August 4, 1999
Movement disorders of autoimmune originF Valldeoriola
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 1999
Therapy of behavioral disorders in Parkinson's diseaseF Valldeoriola, J Molinuevo
Clinical Neuropharmacology|January 1, 1994
Mid-stage parkinsonism with mild motor fluctuationsE Tolosa, F Valldeoriola
AJR. American Journal of Roentgenology|April 1, 1994
Untoward effects of MR imagingE Villegas, F Valldeoriola, A Trilla
Clinical Neurology and Neurosurgery|September 8, 2009
A multicentre retrospective study of the clinical use of ropinirole in the treatment of Parkinson's disease: the ROPI-PARK studyF Valldeoriola, S Cobaleda, J Lahuerta
European Journal of Neurology|November 29, 2013
Progressive supranuclear palsy: clinical and pathological diagnosisE Tolosa, F Valldeoriola, F Cruz-Sánchez
Neurologia (Barcelona, Spain)|February 9, 2002
[Bilateral temporal leukoencephathy in neurosyphilis]Y Blanco, R Sánchez-Valle, F Valldeoriola
Journal of Neural Transmission. Supplementum|January 1, 1994
Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)E Tolosa, F Valldeoriola, M J Marti
Journal of Neural Transmission. Supplementum|January 1, 1997
Treatment of behavioural disturbances in Parkinson's diseaseF Valldeoriola, F A Nobbe, E Tolosa
Advances in Neurology|January 1, 1996
Differential diagnosis and clinical diagnostic criteria of progressive supranuclear palsyF Valldeoriola, E Tolosa, J Valls-Solé
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Journal of Neurology|August 4, 1999
Movement disorders of autoimmune originF Valldeoriola
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 1999
Therapy of behavioral disorders in Parkinson's diseaseF Valldeoriola, J Molinuevo
Clinical Neuropharmacology|January 1, 1994
Mid-stage parkinsonism with mild motor fluctuationsE Tolosa, F Valldeoriola
AJR. American Journal of Roentgenology|April 1, 1994
Untoward effects of MR imagingE Villegas, F Valldeoriola, A Trilla
Clinical Neurology and Neurosurgery|September 8, 2009
A multicentre retrospective study of the clinical use of ropinirole in the treatment of Parkinson's disease: the ROPI-PARK studyF Valldeoriola, S Cobaleda, J Lahuerta
European Journal of Neurology|November 29, 2013
Progressive supranuclear palsy: clinical and pathological diagnosisE Tolosa, F Valldeoriola, F Cruz-Sánchez
Neurologia (Barcelona, Spain)|February 9, 2002
[Bilateral temporal leukoencephathy in neurosyphilis]Y Blanco, R Sánchez-Valle, F Valldeoriola
Journal of Neural Transmission. Supplementum|January 1, 1994
Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)E Tolosa, F Valldeoriola, M J Marti
Journal of Neural Transmission. Supplementum|January 1, 1997
Treatment of behavioural disturbances in Parkinson's diseaseF Valldeoriola, F A Nobbe, E Tolosa
Advances in Neurology|January 1, 1996
Differential diagnosis and clinical diagnostic criteria of progressive supranuclear palsyF Valldeoriola, E Tolosa, J Valls-Solé
Pageof 10